Results 321 to 330 of about 754,612 (422)

Sarcopenia in interstitial lung disease. [PDF]

Eur Respir Rev
Sheehy R, McCormack S, Fermoyle C, Corte T.   +3 more
europepmc   +1 more source

Magnetic Resonance Imaging in the Clinical Evaluation of Lung Disorders: Current Status and Future Prospects

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT The low proton density and high signal decay rate of pulmonary tissue have previously hampered the application of magnetic resonance imaging (MRI) in the clinical evaluation of lung disorders. With the continuing technical advances in scanners, coils, pulse sequences, and image postprocessing, pulmonary MRI can provide structural and ...
Linyu Wu, Chen Gao, Ting Wu, Ning Kong, Ziwei Zhang, Jie Li, Li Fan, Maosheng Xu   +7 more
wiley   +1 more source

Rituximab in systemic sclerosis-associated interstitial lung disease: A systematic review and meta-analysis. [PDF]

Sci Prog
Jang JH, Her M, Oh JH, Park JH, Jung SY, Ko J, Lee JH.   +6 more
europepmc   +1 more source

Size‐specific dose estimates calculated using patient size measurements from scanned projection radiograph in high‐resolution chest computed tomography

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 85-92, March 2025.
This study established that patient's lateral width measurements made from scanned projection radiograph (SPR) is an overestimate compared to those measured from tomographic slices by about 10%. Size‐specific dose estimates (SSDE) calculated using lateral width measured from SPR correlates well with SSDE calculated using water equivalent diameter of ...
Ajit Brindhaban
wiley   +1 more source

Multicystic Interstitial Lung Disease Due to a Novel Biallelic C-C Chemokine Receptor Type 2 Variant. [PDF]

Pediatr Pulmonol
Herkner M, Rapp C, Graeber SY, Marx C, Rambuscheck C, Reu-Hofer S, Emiralioglu N, Kiper N, Gilea AI, Notaroberto I, Baruffini E, Temmesfeld-Wollbrück B, Klein C, Wen H, Stahl M, Griese M, Gothe F.   +16 more
europepmc   +1 more source

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores

Journal of Surgical Oncology, EarlyView.
ABSTRACT Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life.
Erlon de Avila Carvalho, Rachid Eduardo Noleto da Nobrega Oliveira, José Henrique Agner Ribeiro, Jefferson Luís Gross, Cezar Augusto Vendas Galhardo, Heládio Feitosa e Castro Neto, Giovana dos Santos, Reitan Ribeiro, Alexandre Ferreira Oliveira, Rodrigo Nascimento Pinheiro   +9 more
wiley   +1 more source

Diffuse Infiltrative Lung Disease -New Clinical Biomaker in Diffuse Interstitial Pneumonia.

, 2001
Shosaku Abe, Hiroki Takahashi
openalex   +2 more sources

Treatable traits in interstitial lung disease: a narrative review. [PDF]

Ther Adv Respir Dis
Harrison M, Lawler C, Lake F, Navaratnam V, Fermoyle C, Moodley Y, Corte TJ.   +6 more
europepmc   +1 more source

Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Lung ischemia/reperfusion injury (LIRI) is a primary contributor to morbidity and mortality following lung transplantation. Dexmedetomidine (DEX) protects the lungs from I/R injury, but the underlying mechanisms remain uncertain. This paper examined the protective effect of DEX in LIRI and elucidated the potential regulation involved. LIRI was
Chun‐Huan Hu, Ru Qian, Yong‐Bo Wang, Lian‐Di Li, Chun‐Xing Miao   +4 more
wiley   +1 more source

Domiciliary oxygen for interstitial lung disease

, 2001
Alan Crockett, Josephine M Cranston, Nic Antic   +2 more
openalex   +2 more sources